Abstract:From the fermentation broth of the marine-derived Actinoalloteichus cyanogriseus WH1-2216-6, a new 5,5,6-polycyclic tetramate macrolactam (PTM) named 16-hydroxymaltophilin (1) was isolated and identified along with five known analouges, dihydromaltophilin (2), 4-deoxydihydromaltophilin (3), maltophilin (4), xanthobaccin C (5) and FI-2 (6), by means of UV-guided isolation as well as the spectroscopic identification. The cytotoxicities of compounds 1 similar to 5 were tested against the human normal hepatic cell line (L-02) and the seven human cancer cell lines, A549, MCF-7, Jurkat, BXPC-3, HCT-116, PANC-1 and K562. The results showed that compounds 1 similar to 5 were active against the above human cancer cell lines with the IC50 values of 0.1 similar to 9.7 mu mol circle L-1, among which the new compound 1 was the lowest toxic to L-02 cell and the most selective to Jurkat, HCT-116 and BXPC-3 cells with the selection index (SI) of 31.5, 41.4 and 52.4, respectively. The antifungal activities of 1 similar to 6 against Aspergillus fumigatus AF293 were also tested by two-fold dilution method. Compounds 2 and 4 were active against A. fumigatus AF293 with the minimum inhibitory concentration (MIC) values of 3.04 and 6.12 mu mol circle L-1, respectively. To the best of our knowledge, this is the first time to report the antifungal activity of 5,5,6-PTMs against A. fumigatus AF293. Apart from the cytotoxicity of compounds 2 and 3 against A549 and MCF-7 tumor cells lines, the other cytotoxicities were reported here for the first time, indicating the potential use of PTMs as the antitumor and antifungal lead compounds against A. fumigatus.

New Polycyclic Tetramate Macrolactam from Streptomyces Sp. S001

Discovery of a New Polycyclic Tetramate Macrolactam 3-Hydroxycombamide I

Discovery of a New Polycyclic Tetramate Macrolactam Clifednamide K

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Targeted Discovery and Combinatorial Biosynthesis of Polycyclic Tetramate Macrolactam Combamides A–E

New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239

Targeted Isolation of New Polycyclic Tetramate Macrolactams from the Deepsea-Derived Streptomyces Somaliensis SCSIO ZH66.

Bioactive Polycyclic Tetramate Macrolactams From Lysobacter Enzymogenes And Their Absolute Configurations By Theoretical Ecd Calculations

Discovery of Oxidized Polycyclic Tetramate Macrolactams Bearing One or Two Rings Through Combinatorial Pathway Reassembly.

Genome Mining of Marine-Derived Streptomyces sp. SCSIO 40010 Leads to Cytotoxic New Polycyclic Tetramate Macrolactams

Discovery of Three 22-Membered Macrolides by Deciphering the Streamlined Genome of Mangrove-Derived <i>Streptomyces</i> sp. HM190

Deciphering the Biosynthetic Logic for C14 Oxidative Modifications of Polycyclic Tetramate Macrolactams

Polycyclic Macrolactams Generated Via Intramolecular Diels–Alder Reactions from an Antarctic Streptomyces Species

Novel Macrolactams from a Deep-Sea-Derived <i>Streptomyces</i> Species

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

Combinatorial Biosynthesis of Oxidized Combamides Using Cytochrome P450 Enzymes from Different Polycyclic Tetramate Macrolactam Pathways

Discovery and Biosynthesis of Pseudoamides Reveal Enzymatic Cyclization of the Polyene Precursor to 5-5 Bicyclic Tetramate Macrolactams

A new polycyclic tetramate macrolactam from Allostreptomyces RD068384: stereochemistry and antifungal potential

Expanding Polycyclic Tetramate Macrolactam (PoTeM) Core Structure Diversity by Chemo-Enzymatic Synthesis and Bioengineering

Paenimacrolidin, a Novel Macrolide Antibiotic from Paenibacillus Sp. F6‐B70 Active Against Methicillin‐resistant Staphylococcus Aureus

Polycyclic Tetramate Macrolactams from the Marine-Derived Actinoalloteichus Cyanogriseus WH1-2216-6